Oticara
Phase 3Discover Oticara’s innovative treatment for chronic rhinosinusitis (CRS). ENT-delivered, single-dose steroid nasal cream providing effective symptom relief for patients where standard therapies fail.
Founded
2018
Focus
Small Molecules
About
Discover Oticara’s innovative treatment for chronic rhinosinusitis (CRS). ENT-delivered, single-dose steroid nasal cream providing effective symptom relief for patients where standard therapies fail.
Company Info
TypePrivate
Founded2018
LocationCambridge, United States
StagePhase 3
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile